Democratic reps want details on Sovaldi's cost

Democratic members of the U.S. House of Representatives Energy and Commerce Committee requested information on pricing methodology for HCV drug Sovaldi sofosbuvir from Gilead Sciences Inc. (NASDAQ:GILD). In a HCV NS5B polymerase inhibitor in December. ...